pyrazines has been researched along with Smoking Cessation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agaku, IT; Alpert, HR; Connolly, GN | 1 |
| Chawla, PS; Kochar, MS | 1 |
1 review(s) available for pyrazines and Smoking Cessation
| Article | Year |
|---|---|
What's new in clinical pharmacology and therapeutics.
Topics: Abatacept; Acetanilides; Amides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiparkinson Agents; Antirheumatic Agents; Antiviral Agents; Apomorphine; Benzazepines; Cardiovascular Agents; Fumarates; Hepatitis B; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Humans; Hypoglycemic Agents; Immunoconjugates; Multiple Sclerosis; Natalizumab; Nucleosides; Papillomavirus Vaccines; Pharmacology, Clinical; Piperazines; Pyrazines; Pyrimidinones; Quinoxalines; Ranolazine; Sitagliptin Phosphate; Smoking Cessation; Telbivudine; Thymidine; Triazoles; Varenicline; Viral Vaccines | 2008 |
1 other study(ies) available for pyrazines and Smoking Cessation
| Article | Year |
|---|---|
A study of pyrazines in cigarettes and how additives might be used to enhance tobacco addiction.
Topics: Behavior, Addictive; Cues; Humans; Nicotine; Nicotinic Agonists; Pyrazines; Reinforcement, Psychology; Smoking Cessation; Tobacco Industry; Tobacco Products; Tobacco Use Disorder; United States; United States Food and Drug Administration | 2016 |